Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 SEP 7 ... negotiations for a new contract to develop a freeze-dried version of the IMVAMUNE® smallpox vaccine. This potential new project will have no influence on the ongoing RFP-3 BARDA ...
2009 SEP 7 ... negotiations for a new contract to develop a freeze-dried version of the IMVAMUNE® smallpox vaccine. This potential new project will have no influence on the ongoing RFP-3 BARDA ...
2009 AUG 24 ... trials. CMX001 is also being developed as a biodefense agent for the treatment of smallpox and complications associated with smallpox vaccination. In addition, Chimerix expects to ... Viral Therapy, Virology, Chimerix Inc. This article was prepared by AIDS Vaccine Week editors from staff and other reports. Copyright 2009, AIDS Vaccine Week via ...
2009 OCT 12 ... to recent research from the United States, "The search for a 'third'-generation smallpox vaccine has resulted in the development and characterization of several vaccine candidates." ...
2009 SEP 21 ... viruses have proven safe and effective for vaccinating billions worldwide against smallpox, polio, measles, influenza and many other diseases. But killed or severely ... attenuated vaccines don't always work. It also suggests ways to engineer an attenuated vaccine to make it as potent as a live vaccine but as safe as a killed vaccine. ...
2009 JUL 27 ... campaign to vaccinate military personnel and members of the civilian population against smallpox to counter a possible bioterrorism attack. More than 1,200,000 military personnel and ... rates and has prompted discussion about cardiac inflammation and other potential vaccine-associated cardiac complications such as dilated cardiomyopathy (DCM) and myocardial ...
2009 OCT 19 ... against avian- (H5N1) and swine-origin (H1N1) influenza and a combination plague and smallpox vaccine for biodefense. Inviragen had offices in Fort Collins, Colorado and Madison, Wisconsin. ...
2009 SEP 21 ... against avian- (H5N1) and swine-origin (H1N1) influenza and a combination plague and smallpox vaccine for biodefense. Inviragen has offices in Fort Collins, Colorado and Madison, Wisconsin. ...
2009 NOV 1 ... against seasonal and pandemic influenza, hepatitis B, RSV, HIV, pneumococcal, anthrax, smallpox and other diseases. The company's NanoStat™ adjuvant platform technology has ... Allergy and Infectious Diseases, a Division of The National Institute of Health, to fund vaccine research associated with "Innate Immune Receptors and Adjuvant Discovery." NanoBio is ...
2009 JUL 13 ... Italy, Portici, Bacteriology, Biotechnology, Bioterrorism, Biowarfare, Bubonic Plague, Smallpox, Vaccines, Variola Virus, Viral Research, Virology, Yersinia Pestis. This ... at reasonable cost." Rigano and colleagues published their study in Vaccine (Plants as biofactories for the production of subunit vaccines against ...
2009 SEP 7 ... Passport Health (www.passporthealthusa.com) has provided anthrax and smallpox vaccination training and has worked with the U.S. military, federal postal facilities, ... calls with the CDC and will be ready to assist with the administration of the H1N1 vaccine and antivirals as per CDC directives." Firestorm (www.firestorm.com) ...
Subject: Passport Health USA and Firestorm Solutions LLC
2009 OCT 19 ... influenza, herpes simplex viruses, hemorrhagic fever viruses, measles and members of the smallpox and rabies virus families. Scientists have also found that PS is exposed in certain ... therapeutics for HIV, VHF and CMV; studies assessing anti-PS antibodies as vaccines or vaccine adjuvants for the prevention of HIV and other infectious diseases; and studies of ...
2009 JUL 29 ... range of interaction effects in genetic association data. We apply the EC filter to a smallpox vaccine cohort study of single nucleotide polymorphisms (SNPs) and infer a GAIN for a collection ...
2009 JUL 20 ... and replication-deficient vaccinia virus (VACV) that is being evaluated as replacement smallpox vaccine and candidate viral vector. MVA lacks many genes associated with virulence and/or ...
2009 OCT 5 ... methods should prove useful tools in monitoring immune responses to next-generation smallpox vaccines, studying poxvirus immunity, and evaluating therapeutic agents such as vaccinia ... According to recent research published in the journal Clinical and Vaccine Immunology, "Because of the bioterrorism threat posed by agents such as variola virus, ...
2009 NOV 2 ... "The immune response elicited by LC16m8, a candidate smallpox vaccine that was developed in Japan by cold selection during serial passage of the Lister ...
2009 AUG 10 ... "Concerns about the possible use of Variola virus, the Causative agent of smallpox, as a weapon for bioterrorism have led to renewed efforts to identify new antivirals ... Biological Therapy, Bioterrorism, Biowarfare, Immunization, Microscopy, Peptide Vaccine, Smallpox, Treatment, Vaccination, Vaccinia Virus, Variola Virus, Viral Inhibition, ...
2009 AUG 24 ... to better understand poxvirus pathogenesis and to develop a safer vaccine against smallpox. Individuals with atopic dermatitis are excluded from smallpox vaccination because of ...
2009 SEP 28 ... virus was administered widely to humans as a vaccine and led to the eradication of smallpox," researchers in the United States report. "We examined the therapeutic ...
